Serum metabolomics of treatment response in myasthenia gravis von Sikorski, Patricia, Li, Yaoxiang, Cheema, Mehar, Wolfe, Gil I, Kusner, Linda L, Aban, Inmaculada, Kaminski, Henry J

Volltext

Myasthenia gravis: the future is here von Kaminski, Henry J, Sikorski, Patricia, Coronel, S Isabel, Kusner, Linda L

Volltext

Does Surgical Removal of the Thymus Have Deleterious Consequences? von Kaminski, Henry J, Kusner, Linda L, Cutter, Gary R, Le Panse, Rozen, Wright, Cameron D, Perry, Yaron, Wolfe, Gil I

Volltext

MicroRNA and mRNA expression associated with ectopic germinal centers in thymus of myasthenia gravis von Sengupta, Manjistha, Wang, Bi-Dar, Lee, Norman H, Marx, Alexander, Kusner, Linda L, Kaminski, Henry J

Volltext

Guidelines for standard preclinical experiments in the mouse model of myasthenia gravis induced by acetylcholine receptor immunization von Tuzun, Erdem, Berrih-Aknin, Sonia, Brenner, Talma, Kusner, Linda L., Le Panse, Rozen, Yang, Huan, Tzartos, Socrates, Christadoss, Premkumar

Volltext

Editorial: Global excellence in inflammatory diseases: North America 2021 von Kusner, Linda L, Misra, Ravi S, Lucas, Rudolf

Volltext

Acetylcholine receptor antibody–mediated animal models of myasthenia gravis and the role of complement von Kusner, Linda L., Sengupta, Manjistha, Kaminski, Henry J.

Volltext

Survivin as a potential mediator to support autoreactive cell survival in myasthenia gravis: a human and animal model study von Kusner, Linda L, Ciesielski, Michael J, Marx, Alexander, Kaminski, Henry J, Fenstermaker, Robert A

Volltext

Myeloid-derived suppressor cells as a potential therapy for experimental autoimmune myasthenia gravis von Li, Yan, Tu, Zhidan, Qian, Shiguang, Fung, John J, Markowitz, Sanford D, Kusner, Linda L, Kaminski, Henry J, Lu, Lina, Lin, Feng

Volltext

Ablation of IL-17 expression moderates experimental autoimmune myasthenia gravis disease severity von Aguilo-Seara, Gabriela, Xie, Yanchen, Sheehan, Jarrod, Kusner, Linda L., Kaminski, Henry J.

Volltext

The Presence of Survivin on B Cells from Myasthenia Gravis Patients and the Potential of an Antibody to a Modified Survivin Peptide to Alleviate Weakness in an Animal Model von Zhang, Xiangyang, Ciesielski, Michael, Fenstermaker, Robert A, Kaminski, Henry J, Kusner, Linda L

Volltext

Serum metabolomic response of myasthenia gravis patients to chronic prednisone treatment von Sengupta, Manjistha, Cheema, Amrita, Kaminski, Henry J, Kusner, Linda L

Volltext

Guidelines for pre-clinical assessment of the acetylcholine receptor-specific passive transfer myasthenia gravis model—Recommendations for methods and experimental designs von Kusner, Linda L., Losen, Mario, Vincent, Angela, Lindstrom, Jon, Tzartos, Socrates, Lazaridis, Konstantinos, Martinez-Martinez, Pilar

Volltext

Role of miRNAs in Normal and Myasthenia Gravis Thymus von Cron, Mélanie A, Guillochon, Émilie, Kusner, Linda, Le Panse, Rozen

Volltext

Elevated plasma interleukin-17A in a subgroup of Myasthenia Gravis patients von Xie, Yanchen, Li, Hai-feng, Jiang, Bin, Li, Yao, Kaminski, Henry J., Kusner, Linda L.

Volltext

Targeting therapy to the neuromuscular junction: Proof of concept von Kusner, Linda L., Satija, Namita, Cheng, Georgiana, Kaminski, Henry J.

Volltext

Investigational RNAi Therapeutic Targeting C5 Is Efficacious in Pre-clinical Models of Myasthenia Gravis von Kusner, Linda L., Yucius, Kristina, Sengupta, Manjistha, Sprague, Andrew G., Desai, Dhruv, Nguyen, Tuyen, Charisse, Klaus, Kuchimanchi, Satya, Kallanthottathil, Rajeev, Fitzgerald, Kevin, Kaminski, Henry J., Borodovsky, Anna

Volltext

The role of complement in experimental autoimmune myasthenia gravis von Kusner, Linda L., Kaminski, Henry J.

Volltext

Molecular architecture of the neuromuscular junction von Hughes, Benjamin W., Kusner, Linda L., Kaminski, Henry J.

Volltext

Editorial: Advances in Autoimmune Myasthenia Gravis von Punga, Anna Rostedt, Kusner, Linda, Berrih-Aknin, Sonia, Le Panse, Rozen

Volltext